Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% [Yahoo! Finance]
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Orchestra BioMed (NASDAQ:OBIO) had its "overweight" rating reaffirmed by analysts at Barclays PLC.